Viking Therapeutics, Inc. (VKTX) Leerink World Healthcare Convention 2026 March 10, 2026 10:40 AM EDT
Firm Members
Brian Lian – President, CEO & Director
Neil Aubuchon – Chief Industrial Officer
Convention Name Members
Thomas Smith – Leerink Companions LLC, Analysis Division
Presentation
Thomas Smith
Leerink Companions LLC, Analysis Division
Nice. Good morning, everybody. Thanks for becoming a member of us right here at day 2 of the Leerink Companions World Healthcare Convention. My identify is Tom Smith. I am one of many senior biotech analysts right here at Leerink. And it is my pleasure to welcome our subsequent firm to the stage, Viking Therapeutics, joined by CEO, Brian Lian; CFO, Greg Zante; and Chief Industrial Officer, Neil Aubuchon. Gents, thanks for becoming a member of us. Trying ahead to the dialogue.
Brian Lian
President, CEO & Director
Thanks.
Query-and-Reply Session
Thomas Smith
Leerink Companions LLC, Analysis Division
Such a dynamic house, weight problems. A whole lot of developments, clearly, and also you guys had a terrific 12 months of execution in ’25, numerous knowledge units developing right here in ’26 after which some essential pivotal knowledge coming in ’27. Assume there’s in all probability a excessive consciousness of what you guys are as much as within the viewers. However Brian, perhaps if you wish to simply discuss by way of a few of that execution in ’25 and what you are trying ahead to right here within the 12 months forward?
Brian Lian
President, CEO & Director
Sure. Sure. ’25 was an enormous 12 months for us. ’26 goes to be an enormous 12 months as nicely. However in ’25, I feel the large accomplishments there have been to get our registration program underway for our twin agonist, VK2735, two Part III trials underway, VANQUISH -1 and VANQUISH-2. We began these round midyear, and we have enrolled the VANQUISH-1 research in weight problems within the fourth quarter. After which the VANQUISH-2 research, we count on to enroll very shortly right here. So each of them enrolled somewhat extra rapidly than we